Biotech Stocks Pressured, Again (IBB)

Biotech stocks declined early on Thursday, with iShares Nasdaq Biotechnology ETF (Nasdaq: IBB) lower by about 3%. The group is down over 10% in the past month.

Notable decliners included popular stocks like Pharmacyclics Inc. (Nasdaq: PCYC), Gilead Sciences Inc. (Nasdaq: GILD), Biogen Idec Inc. (Nasdaq: BIIB) and Celgene Corporation (Nasdaq: CELG), to name a few.

You May Also Be Interested In

• Exclusive-US weighs polysilicon price floor, tariffs to counter China in solar and chips
• Exclusive-White House set to extend Jones Act waiver as Trump hunts for cheaper gasoline
• Goldman Sachs raises Q3 US GDP forecast to 2.7% on trade data